Prostaglandin 9-ketoreductase (PG-9-KR) was purified from pig kidney to homogeneity, as judged by SDSjPAGE using an improved procedure. The enzyme is p r o 3 stereoselective with regard to hydrogen transfer from NADPH with prostaglandin E2 as substrate and reduces its 9-keto group with approximately 90% stereoselectivity to form prostaglandin F2.. Approximately 8% of the prostaglandin F formed has the P-configuration. In addition to catalyzing the interconversion of prostaglandin E2 to FZa, PG-9-KR also oxidizes prostaglandin E2, FZa and D2 to their corresponding, biologically inactive, 15-keto metabolites. Incubation of PG-9-KR with prostaglandin F2, and NAD+ leads to the preferential formation of 15-keto prostaglandin FZa rather than prostaglandin E2. This suggests that the prostaglandin E2/prostaglandin Fza ratio is not determined by the NADP' /NADPH redox couple. The enzyme also reduces various other carbonyl compounds (e.g. 9,lO-phenanthrenequinone) with high efficiency. The catalytic properties measured for PG-9-KR suggest that its in vivo function is unlikely to be to catalyze formation of prostaglandin F2,. The monomeric enzyme has a molecular mass of 32 kDa and exists as four isoforms, as judged by isoelectric focusing. PG-9-KR contains 1.9 mol Zn2+/mol enzyme and no other cofactors. Human kidney PG-9-KR was also purified to homogeneity. The human enzyme has a molecular mass of 34 kDa and also exists as four isoforms. Polyclonal antibodies raised against pig kidney PG-9-KR cross-react with human kidney PG-9-KR and also with human brain carbonyl reductase, as demonstrated by Western blot analysis. Sequence data of tryptic peptides from pig kidney PG-9-KR show >90% identity with human placenta carbonyl reductase. From comparison of several properties (catalytical, structural and immunological properties), it is concluded that PG-9-KR and carbonyl reductase are identical enzymes.
1974 [16] . Although several other papers have appeared which describe the purification of the enzyme from different sources and its partial characterization [6, 9-11, 13, 15, 17-21] , its catalytic properties and regulation are still not understood in detail.
In contrast to other classical prostaglandins, like PGE2 or prostaglandin D2 (PGD2), whose biosynthetic pathways are well established, the origin of PGF2, is still uncertain. Several possibilities have been suggested for its formation (Scheme l), such as 9-keto reduction of PGE2 [l] ; 11-keto reduction of PGD2 [22] ; direct reduction of the endoperoxide of prostaglandin H2 (PGH2) [22-241; synthesis of PGF2, via the endoperoxide prostoglandin G 2 and 15-hydroperoxy PGF2, [25] (not shown). This latter pathway, recently discovered, is rather unlikely in view of the tight coupling of the cyclooxygenase and peroxidase activities of prostoglandin endoperoxide synthase.
As PG-9-KR catalyzes the interconversion of the physiologically antagonistic prostaglandins E2 and Fza in vitro, it has been proposed to have an in vivo regulatory function in prostaglandin metabolism. Schlegel et al. [I31 and Krueger and Schlegel[26] assume that this enzyme might be important in regulating the events leading to labour and delivery during First publ. in: European Journal of Biochemistry 206 (1992) , 2, pp. 491-502 Konstanzer (2) PGF2, synthase; (3) PGD, isomerase; (4) PGEZ isomerase; (5) PG-9-KR. birth, by controlling the PGE2/PGF2, ratio in the decidua veru. Other authors suggest the participation of PG-9-KR in the prostaglandinlrenin-mediated sodium intake and excretion by the kidney [27, 28] and its involvement in developing hypertension [29] . It has also been pointed out that assignment of a specific, significant role of PG-9-KR in prostaglandin metabolism must be considered with caution, due to its nonphysiologically high K, value for PGE, [8, 191 , its capacity to also act on the prostaglandin 15-hydroxyl group (a reaction that leads to the formation of the biologically inactive 15-keto prostaglandins) [30] and from the findings that the enzyme is also active in the oxidoreduction of various non-prostaglandin carbonyl compounds [18, 311. Thus, the physiological significance of PG-9-KR in prostaglandin metabolism (i. e. PGFza formation) is uncertain.
Along this line, Wermuth [32] has proposed that PG-9-KR might be related to or even identical with carbonyl reductase, an enzyme he first purified from human brain. So far, the physiological role of carbonyl reductase is unknown. Carbonyl reductase belongs to a group of enzymes called aldoketo reductases [33] and shows several similarities with PG-9-KR. Both are cytosolic, monomeric enzymes with a molecular mass of approximately 30 kDa which exhibit a specificity for NADPH as the preferred coenzyme. Chang and Tai [18] have also suggested PG-9-KR to be a less specific carbonyl reductase. In contrast, Jarabak et al. [31] conclude, on the basis of kinetic measurements, that PG-9-KR and carbonyl reductase are not identical enzymes. With the current uncertainty in the literature regarding the biological significance of PG-9-KR in prostaglandin metabolism and its possible identity with carbonyl reductase, this study was undertaken to attempt to resolve some of these questions. Our approach was to highly purify PG-9-KR from a convenient source (pig kidney and, subsequently, human kidney) which would provide sufficient amounts of enzyme to permit extensive characterization. To facilitate a detailed product analysis of the action of PG-9-KR on prostaglandins, an HPLC assay system was established rather than the commonly used radioimmunoassay [3, 8, 13, 171. 
EXPERIMENTAL PROCEDURES Materials
Low molecular mass standards for SDS-gel electrophoresis, a broad p l calibration kit for isoelectric focusing, Sephacryl S200, hydroxyapatite Ultrogel and Sepharose red were purchased from Pharmacia/LKB (FRG). Prostaglandins, 9,lO-phenanthrene quinone, bovine serum albumin and TEAE-cellulose were obtained from Sigma (FRG). [l-''C]PGE2 (0.038 mM, 0.037 MBq/ml) and [1-3H] Glc (0.066 pM) were obtained from New England Nuclear (FRG). Pyridine nucleotides, glucose 6-phosphate (glc-6-P), yeast Glc-6-P dehydrogenase grade I, hexokinase, ATP, horse alcohol dehydrogenase and dithiothreitol were supplied by Boehringer Mannheim (FRG) . Human brain carbonyl reductase was a kind gift from Prof. Dr. B. Wermuth, University of Bern, Switzerland. Ether (Uvasol quality), acetonitrile, hexane and zinc standard solution were obtained from Merck (FRG). Scintillation cocktail (Quickszint 402) was purchased from Zinsser (FRG). PGF,, was prepared from PGE2 by sodium borohydride reduction [34] . All other chemicals were of the highest purity commercially available.
Methods

Enzyme assays using HPLC method 1
This method was used to quantify the reduction of PGE, to PGF,, during enzyme purification. The assay mixture contained 56.5 pM PGE2, approximately104 cpm [1-14C]-PGE,, 200 pM NADPH, an aNADPH-generating system (2.8 mM Glc-6-P and 0.07 U Glc-6-P dehydrogenase) and enzyme (10 -100 pl) in 200 mM Tris/HCl, pH 8.0, in a final volume of 0.5 ml. Blanks without enzyme were routinely included. The reaction was allowed to proceed at 37°C for 60 min, then terminated by the addition of 75 pl 1.5 M citric acid (adjusting the pH to 3.5). After addition of 3 pg PGF2m as carrier and internal standard, prostaglandins were extracted twice with 1.5 ml ether/hexane (6: 1, by vol.) . The organic phase, containing prostaglandins, was e\ aporated to dryness under a steam of N,, subsequently dissolved in 0. 21111 acetonitrile/H,O/acetic acid (35: 65:0.1, by vol.) and separated by reverse-phase HPLC (100 RP-1 8e Lichrospher column from Merck, FRG; flow rate, 1 ml/min). This system allows baseline separation of PGE2 and PGFza . The identification of the eluted peaks was made on the basis of elution times, checked daily with known standards, which were typically approximately 9 min for PGF,, and approximately 11 min for PGE,, The eluted fractions were counted in 10 ml scintillation cocktail (1 min counting time, using a Beckmann LS 1801 scintillation counter). One unit (U) enzyme activity is defined as the amount of enzyme which catalyies the formation of 1 pmol PGF,,/min.
Enzyme assays using HPLC method 2
This method was used for determining the substrate specificity with respect to the 9-keto/hydroxyl or 15-keto group of PGE2, PGF2, and PGD,. The assay conditions and procedure polyacrylamide gels as described by Weber et al. [39] . The FPLC column (TSK G200 SW, Pharmacia/LKB, FRG) was equilibrated and eluted with 50 mM potassium phosphate, pH 7.4, containing 0.15M NaCl, 1 mM dithiothreitol and 1 mM EDTA.
were as described above, but the NADPH-generating system, radioactive prostaglandin and the internal standard were omitted. Prostaglandin concentrations were 113 pM each. For investigating the oxidative enzyme activity, 0.2 mM NADP ' was used in the assay mixture. The enzyme source was homogeneous PG-9-KR obtained from Sepharose red chromatography. All assays were performed in duplicate. As a control, enzyme was omitted from the assay mixture. All prostaglandins, including their 15-keto metabolites, were eluted by baseline separation using this system. Product identification was by comparing elution times with those of known standards, and quantification was by graphically determining the peak areas.
Spectrophotometric assay
The reduction of various carbonyl compounds was monitored by following the NADPH oxidation at 340 nm (Uvicon Spectrophotometer 830 or 910) and 25°C. The assay mixture was composed of 0.2 mM NADPH, various concentrations of substrate (listed in Table 3 ) and enzyme in 200 mM potassium phosphate, pH 6.5, containing 1 mM EDTA in a total volume of 1 ml. For assaying the 9,lO-phenanthrenequinone reduction during enzyme purification, 0.1 mM 9,lO-phenanthrenequinone was used. The reaction was initiated by the addition of enzyme. Blanks without enzyme were routinely included. 1 U enzyme activity is defined as the change in absorbance corresponding to the oxidation of 1 pmol NADPH/min.
Protein determination of Bradford [35] using bovine serum albumin as standard.
The protein concentration was determined by the method
Sequence determination
For tryptic digestion, homogeneous protein from pig kidney was dissolved in 0.1 M N-ethylmorpholine/acetate, pH 8.1, at a concentration of 1 mg/ml. Trypsin was added at a ratio of 1: 30 (trypsin/substrate, by mass), incubated at 37 "C for 6 h and immediately followed by lyophilisation. The peptides were separated by HPLC (Hewlett Packard 3 090 liquid chromatograph) using a 1.9 mm x 250 mm Vydac 218TP5 column. Sequence analysis was performed in a gasphase sequencer constructed and operated as described [36] .
S D S/ PAG E
SDSjPAGE was performed in 12.5% gels as described by Laemmli [37] . Protein bands were visualized with Coomassie brilliant blue R-250 and with silver staining [38] .
Isoelectric focusing
Isoelectric focusing was performed on thin-layer polyacrylamide gels (Precotes, pH 4-7, from Serva, FRG) as described by the manufacturer. Gels were focused for 3 h at a maximal electrical output of 4 W and stained with Coomassie brilliant blue R-250.
Molecular muss
The molecular mass of the enzyme was determined by FPLC gel filtration and by electrophoresis in 12.5% SDS/ 
65%.
Purification of PG-PKR jrom pig kidney All steps were carried out at 4°C. Pig kidneys (500 g, obtained from the local slaughter house) were homogenized in 2 vol. 10 mM Tris/HCl, pH 7.4, containing 1 mM dithiothreitol and 10% glycerol (by vol.) (buffer A) in a Waring Blendor for three 1-min periods, and the homogenate centrifuged for 50 min at 27 000 xg. The pH of the supernatant was adjusted to pH 5.0 and the precipitate removed by centrifugation at 27 000 x g for 50 min. The pH of the resulting supernatant (containing PG-9-KR) was readjusted to pH 7.4, ammonium sulfate added to 80% saturation and centrifuged as described above. The precipitate was dissolved in a minimal volume of buffer A and dialyzed for 24 h against three 5-1 changes of buffer A. The dialyzed protein solution was applied to a TEAE-cellulose column (Scm x 25 cm, in buffer A). After removal of unbound protein by washing the column with buffer A, PG-9-KR was eluted with a linear gradient of 0-1000 mM NaCl in buffer A (flow rate, 60 ml/ h; fraction size, 20 ml). Fractions which contained PGE2 and 9,lO-phenanthrenequinone activity were pooled and the proteins precipitated with 80% ammonium sulfate. After dialysis against three 5-1 changes of 50 mM potassium phosphate, pH 7.4, containing 1 mM EDTA, 1 mM dithiothreitol and 10% glycerol (by vol.) (buffer B), the solution was centrifuged for 15 min (27 OOOxg), applied to a Sephacryl S200 column(6.5 cm x 95 cm, in buffer B) and eluted with buffer B (flow rate, 25 ml/h, fraction size, 18 ml). Active fractions were pooled, dialyzed versus three changes of 5 mM potassium phosphate, pH 6.2, containing 1 mM EDTA, 1 mM dithiothreitol and 10% glycerol (by vol.) (buffer C) and applied to a hydroxyapatite column (1.6 cm x 25 cm, in buffer C; flow rate, 25 ml/h, fraction size, 5 ml). After removal of unbound protein by washing the column with buffer C, PG-9-KR was eluted with a linear gradient of 10-100 mM buffer C, the active fractions pooled, the pH adjusted to 7.4, concentrated with Centriprep 10 (Amicon) and dialyzed against 40 mM potassium phosphate, pH 7.4, containing 1 mM EDTA, 1 mM dithiothreitol and 10% glycerol (by vol.) (buffer D). This fraction was applied to a Sepharose red column (0.8 cm x 6 cm, in buffer D ; flow rate, 12 ml/h, fraction size, 1 ml). After washing the column with buffer D, PG-9-KR was eluted with 9 -12 ml 1 mM NADPH in buffer D. Active fractions were pooled and dialyzed against buffer B. The purified PG-9-KR was stored at 4°C.
Purification of PG-9-KR from human kidney
The purification of the enzyme from human kidney was carried out from 200 g tissue, kindly provided by the kidney transplant unit of the University Hospital of Zurich. Only healthy tissue sections were used. The purification was essentially the same as that employed for the isolation of PG-9-KR from pig kidney and is summarized in Table 1 . It is worth mentioning, that the elution profiles of the TEAE-cellulose and hydroxyapatite chromatography differ qualitatively (not shown). PG-9-KR from human kidney did not bind to these columns and was eluted during the washing step.
Production of antiserum
Antiserum was generated against purified PG-9-KR (pig kidney) by immunizing an adult rabbit subcutaneously with 200 pg enzyme (pooled Sepharose red fraction) emulsified with an equal volume of Freund's complete adjuvant. After six weeks, a second immunization with 200 pg enzyme was given. The antiserum was collected 1 0 d after the second immunization. Control serum was collected before the first immunization.
Western-blot analysis
Western blots from 12.5% polyacrylamide gels were performed in a Bio-Rad trans-blot cell according to the method of Towbin et al. [43] . The transfer was carried out at 4'C for 90 min at 90 V. After blocking the nitrocellulose membrane with 3% (massivol.) bovine serum albumin in 10 mM KPi and 0.9% (massjvol.) NaC1, pH 7.4 (NaC1/Pi), i f was incubated with rabbit antb(PG-9-KR) serum, diluted 1: 500 (by vol.) in 1% (mass/vol.) bovine serum albumin/ NaC1/Pi. The secondary incubation was with horseradishperoxidase-conjugated protein A, diluted 1 : 1000 (by vol.) in 1 % (mass/vol.) bovine serum albumin/NaC1/Pi (Sigma, FRG). The color development was carried out in 4-chloro-1-naphtol (Sigma, FRG) and hydrogen peroxide [44] . The membrane was washed with several changes of NaC1/Pi after each incubation step.
Amino acid composition
Aliquots of purified homogeneous pig kidney enzyme were dialyzed against water, lyophilized, then hydrolyzed with 6M HC1 for 24, 48, 72 and 96 h at 110°C. Amino acid analyses were performed on a Biotronik amino acid analyzer. Values for serine and threonine were extrapolated to 'zero time' of hydrolysis. All other values were the averages of the data at the various times. The amino acid composition was calculated assuming a molecular mass of 30 000 Da.
Atomic absorption measurement
Purified PG-9-KR from pig kidney was dialyzed for 4 d against several changes of Millipore water. The zinc content of the enzyme was measured with a Perkin Elmer atomic absorption spectrophotometer using a graphite tube with platform. The absorption of the sample was measured at 213.9 nm for 2 s at 1800°C. Argon was used for the internal gas flow. A solution of zinc (Merck, FRG) was used as an internal standard. The dialysate was used as blank.
RESULTS AND DISCUSSION
Enzyme purification
Our purification procedure is based on that described by Chang et al. [30] . The modifications described allow the purification of larger quantities of enzyme. Enzyme purifications from pig kidney and from human kidney are summarized in Table 1 and resulted in homogeneous enzymes as demonstrated by single bands in SDSjPAGE (Figs. 1 and 2 ). The two enzymes can essentially be purified by the same procedure. A new, crucial step in the purification, which affects both the final purity and the ease of assaying enzyme activity, was the pH 5.0 precipitation, which removes substantial amounts of protein, including the 'type 1' or 'NAD+-dependent' prostaglandin-1 5-dehydrogenase (which also uses PGEz as substrate and therefore interferes with enzyme assay measurements) but leaves the activity of PG-9-KR essentially unaffected. Since the enzyme exhibits a broad substrate specificity [18, 311, the activity was measured using two complementary methods; the reduction of PGEz to PGFz, is assayed with HPLC (method 1) and the reduction of 9,lO-phenanthrenequinone is monitored spectrophotometrically. The application of the two assay methods ensured that similar enzyme activities were not overlooked. This is exemplified by the TEAE-cellulose elution profile shown in Fig. 3 , which shows the separation of the PG-9-KR activity from two other activities, which also oxidize NADPH but lack the ability to reduce PGEz. The identity of these two other activities was not investigated further. It is important to point out that, during all subsequent purification steps, the PG-9-KR activity and the quinone reductase activity comigrate and the same ratios of their activities are found. This is exemplified by the Sephacryl S200 chromatography elution profile of human kidney PG-9-KR, depicted in Fig. 4 . These data, together with the observation of a single band on SDS/PAGE, strongly suggest the presence of a single enzyme catalyzing both activities. These results are in contrast with the assumption of Jarabak et al. [31] , who attributed the quinone-reducing activity to an impurity, and support the hypothesis of Wermuth [32] that PG-9-KR and carbonyl reductase are closely related enzymes. In our hands, subsequent to the TEAE-cellulose step, the 9,lO-phenanthrenequinone reduction can be used as an easy and very sensitive assay for the detection of the PG-9-KR. This also contrasts with the report of Watkins and Jarabak [45] , which could not correlate the two activities during purification of PG-9-KR and therefore lead to the conclusion, that 9,lO-phenanthrenequinone is an inappropriate substrate for assaying PG-9-KR. Removal of the coenzyme (NADPH) by dialysis at the end of the purification procedure (Sepharose red chromatography) is important to prevent enzyme inhibition. Table 1 . Purification of PG-9-KR from kidney. Pig, enzyme isolated from pig kidney; Hu, enzyme isolated from human kidney. Activities measured using either PGE2 or 9,lO-phenanthrenequinone (PQ) as substrates were monitored by HPLC method 1 and spectrophotometrically, respectively. One enzyme unit (U) is defined as the formation of 1 pmol PGF,,/min, or as the oxidation of 1 pmol NADPH/min at 37°C. The activity could not be determined reliably prior to the pH 5.0 precipitation step. 
Molecular mass and isoelectric point
The apparent molecular mass of the pure, native pig kidney enzyme, determined by FPLC gel filtration as described in Experimental Procedures, is approximately 28 kDa. The values, obtained by SDS/PAGE, were approximately 32 kDa for pig kidney PG-9-KR and approximately 34 kDa for the human kidney PG-9-KR, confirming previous results [19, 21, 261 , that PG-9-KR is a monomeric enzyme.
Isoelectric focussing of the purified, homogeneous PG-9-KR forms (see Figs. 1 and 2 5.25, 5.3, 5.45 and 5.5 for the human kidney enzyme. These results indicate that there are significant differences in the surface charges of these two enzymes, the human one being slightly more basic. This is also reflected by their different elution behaviors on TEAE and hydroxyapatite chromatography, as described in Experimental Procedures. The existence of different PG-9-KR forms, which differ only in their respective pZ values, has also been reported by others [6, 10, 16, 26, 461 . In our case, however, the different forms are not separable during purification, but only by isoelectric focussing. Whether these different enzyme forms are due to posttranslational modifications or to differences in amino acid sequence is not known. It should be pointed out that multiple enzyme forms are also observed within the class of carbonyl reductase and ketone reductase [32, 47] .
Substrate specificity and catalytic properties
Since the amount of human PG-9-KR was limited, these studies were carried out only with PG-9-KR from pig kidney. However, tests carried out under the same conditions with the human enzyme indicated a similar behavior for both enzymes (human and pig kidney).
The specificity of PG-9-K R for keto or hydroxyl residues of prostaglandins at position C9, C11 or C15, was investigated by incubating the enzyme with PGE2, PGFz, or PGD2 and the respective coenzyme (NADPH or NADP'). The resulting reaction products were analyzed by HPLC method 2 (Experimental Procedures).
The results, summarized in Table 2 , demonstrate that incubation of the enzyme with PGE2, PGF2, or PGD2 with NADP' led to the formation of their corresponding 1 5-keto metabolites (reaction 3 in Scheme 2). These data confirm published results by Lee and Levine [16] and Chang and Tai [19] , who used radioimmunoassay to show that PG-9-KR can also function as a prostaglandin-1 5-dehydrogenase (this activity is referred to in the literature mainly as 'type 2' or 'NADP+-dependent' prostaglandin-1 5-dehydrogenase). This means that PG-9-KR not only catalyzes the interconversion of PGEz and PGFza (reaction 1 in Scheme 2), which generally function physiologically as antagonists, but also catalyzes their biological inactivation. It is, however, unlikely, that this 'type 2' prostaglandin-1 5-dehydrogenase activity has major physiological significance, since the 'type 1 ' (or NAD +-dependent) prostaglandin-I 5-dehydrogenase has a much higher activity in catalyzing this reaction [48] . Upon incubation of PG-9-KR with PGDz and NADPH, no PGF2, could be detected (reaction 2 in Scheme 2). Further studies showed that the enzyme does not catalyze the conversion of PGFz, to PGD2, Therefore, PG-9-KR catalyzes conversions of keto or hydroxyl groups of prostaglandins at positions C9 and C1S but not C1 1.
Incubation of PG-9-KR with PGF2,, and NADP' leads to the preferential formation of 15-keto PGF2. (434G) and not PGE2 (only 10%; see Table 2 ). Accordingly, PG-9-KR, and thereby the PGE2/PGF2, ratio within the cell, are unlikely to be regulated by the NADPHiNADP' ratio as suggested by Ziboh et al. [7] or Chang and Tai [19] .
The specificity of PG-9-KR for 'non-prostaglandin substrates' was studied using the compounds listed in Table 3 . The rate of reduction of 4-nitrobenzaldehyde was set at loo%, allowing direct comparison of the results with carbonyl reductase isolated from human brain [32] or pig brain [49] and PG-9-KR isolated from human placenta or rabbit kidney [31] . The quinones, 9,lO-phenanthrenequinone and menadione, were reduced about 1000 times faster than PGEz. Although vitamin K3 (menadione) was a good substrate, no reduction of vitamin K1 (phylloquinone) or vitamin K2 (menaquinone) could be detected. It seems unlikely, therefore, that PG-9-KR is involved in vitamin K metabolism, as suggested by Chang and Tai [18] . a-Tocopherolquinone, the oxidation product of vitamin E, is reduced at a rate similar to that found for PGE2. 4-Nitrobenzaldehyde and the aromatic aldehyde phenylglyoxal are also good substrates. All steroids investigated were only poor substrates. The substrate specificity study confirms that PG-9-KR is not a prostaglandin-specific enzyme, but exhibits a general aldo-keto-reductase activity as originally proposed by Chang and Tai [18] . A broad substrate specificity has also been described for PG-9-KR from human placenta and from rabbit kidney [31] . These results further support the hypothesis of Wermuth [32] that PG-9-KR and carbonyl reductase are closely related enzymes. Ketone reductase from chicken kidney [47] is another enzyme which might belong to the same family, as judged from its broad substrate specificity. Table 4 shows turnover ratios of the above-mentioned enzymes with various substrates. All enzymes listed show similar relative activities towards these substrates. The observed differences probably result from different enzyme sources or from varying assay conditions. The substrate specificities further support the notion that PG-9-KR, carbonyl reductase and possibly also ketone reductase, are closely related enzymes. The pH optimum of PG-9-KR (pig kidney) activity differs, depending on whether prostaglandin or quinone is used as substrate. With PGEz as substrate, the activity was constant over pH 7.8-9.0 and decreased only slightly (by 20%) at pH 5.0. This behavior has also been observed by others [8, Table 3 . Substrate specificity of PG-PKR (pig kidney) for various carbonyl compounds. The enzyme source was PG-9-KR obtained after hydroxyapatite Ultrogel chromatography. The activity was measured as described in Experimental Procedures (spectrophotometric assay), and the value for 4-nitrobenzaldehyde was set at 100%. The activities with vitamin K1, KZ and a-tocopherolquinone were determined in the presence of 0.1% Triton X-100. and that with dichloroindophenol was monitored at 600 nm ( E = 20 cm2!mM).
Substrate
Concen 15, 501. With menadione as substrate, however, the enzyme activity had a pH optimum of pH 6.2-6.8, as is also found for carbonyl reductase [32] .
The Michaelis constants (K,) and maximal velocities (V,,,,,) were determined for selected substrates and are listed in Table 5 . The best substrate for PG-9-KR (pig kidney), as deduced from k,,JK,,, values, is 9,lO-phenanthrenequinone. The kca,/Km value for prostaglandin E2 is approximately Table 4 . Comparison of relative velocities of PG-9-KR, carbonyl reductase and ketone reductase using various carbonyl substrates. The activity with 4-nitrobenzaldehyde was set at 100%. The activities with PG-9-KR from kidney were measured with the pig enzyme, however, it was determined that the enzyme from human kidney exhibited essentially the same behavior in selected comparative assays carried out under the same conditions. n.d. = not determined. PG-9-KR from kidney, this work; PG-9-KR from human placenta from [31] Table 5 . Kinetic parameters of kidney PG-9-KR for selected substrates.
The limited amount of human kidney PG-9-KR did not allow a comprehensive kinetic characterization, however, essentially the same behavior was observed in selected comparative assays carried out under the same conditions. K, and V,,, values were determined from Eddie-Hofstee plots. k,,, was calculated on the basis of a molecular mass of 30 kDa for PG-9-KR (pig kidney). The concentration of NADPH used for the determination of the K, of substrates was 100 FM. To determine the K, of NADPH, 4-nitrobenzaldehyde (500 pM) was used as a substrate. The values for PGEz were determined with HPLC method 1 ; in this specific case the incubation time was reduced to 30min. The values for the other substrates were determined spectrophotometrically. Details are described in the Experimental Procedures. n.d., data not available. 10 000 times lower and, thus, is comparatively a very poor substrate. PG-9-KR exhibits a high K , value for PGE2 (160 pM), which is about 1000-10 000 times higher than tissue levels of prostaglandins (1 -100 nM). These data suggest that the function of this enzyme is unlikely to be PGF?, formation in vivo. As mentioned above, there are several alternative enzymes which could account for PGF2, synthesis (see Scheme 1). The K, values observed for those enzymes, PGF2,-synthetase [15] , selenium-dependent glutathione peroxidase (GSH, glutathione) and non-selenium-dependent GSH peroxidase [25] , for their corresponding prostaglandin substrates are high (approximately 10 -100 pM) relative to the in vivo prostaglandin concentration. These considerations also raise doubts regarding their respective in vivo roles in prostaglandin metabolism. It is worthwhile mentioning that PGFz, synthetase, like PG-9-KR, has a broad substrate specificity, with quinones as the best substrates [15].
PGF2, synthetase catalyzes the reduction of the 11 -keto group of PGD2 and thus can be distinguished from PG-9-KR which is non-reactive towards this position (see ' Table 2 ). Comparison of the velocities of these enzymes shows that the peroxidase activity of GSH transferase isozyme IV [23] is about 100 times faster in PGF2, formation than PG-9-KR or PGF2, synthetase formation (approximately 6000 mU/mg versus approximately 60 -80 U/g). From these considerations we therefore conclude that PG-9-KR is not physiologically significant in PGFza synthesis. Table 6 summarizes K,, Vmax and k,,, values for the following enzymes from different sources: PG-9-KR (also referred to as 'type 2' prostaglandin-1 5-dehydrogenase in the literature), carbonyl reductase and ketone reductase. In general, all enzymes show non-physiologically high K, values and variable, but small, V,,, values for PGE2. Even V,,, values for the same enzyme, isolated from different sources, vary significantly. The salient point to be made is that these enzymes reduce quinones and 4-nitrobenzaldehyde much faster than PGE2 or prostaglandin El (PGE1). From these data, we conclude that PG-9-KR possess, in principle, the same catalytic properties as carbonyl and ketone reductases. This statement contrasts with the conclusion of Jarabak et al. [31] , who, using similar considerations, propose that PG-9-KR and carbonyl reductase are different enzymes.
Stereospecificity
Incubation of pig kidney PG-9-KK with (4S)-[3H]-NADPH yielded approximately 86% radiolabeled PGFz, and only approximately 6% radiolabeled product upon incubation with the 4R radiolabeled enantiomer. Therefore, PG-9-KR catalyzes pro-S stereoselective hydrogen transfer from NADPH and shares this highly conserved enzyme property [51] with carbonyl reductase [32] . The stereospecificities of other PG-9-KR forms have not been investigated so far. This finding also suggests that PG-9-KR differs from mammalian, plant or yeast alcohol dehydrogenases, which are pro-R enzymes [52] .
All naturally occurring prostaglandins have an a configuration, i.e. substituents of the cyclopentane ring have the same orientation as the aliphatic side chain carrying the carboxylate (see Scheme 3) [53] . The stereospecificity of the reduction of the C9 keto group of PGE,, which could lead in principle to either the CI or the p stereoisomer of prostaglandins, has not yet been investigated. We have analyzed the reaction products with HPLC method 1 (in this case PGFzo, and PGF,, were added as internal standards to the incubation mixture at the end of the reaction), which allows a baseline-separated elution of PGF,, and PGF,,. Homogeneous PG-9-KR reduced PGE, to only approximately 90% PGF,,, while, unexpectedly, approximately 6-8% of the formed prostaglandin had the configuration. The level of PGF,, was significantly above the background level.
Spectral properties and metal content
The absorption spectrum of the purified PG-9-KR (pig kidney) shows no absorbance in the visible or near ultraviolet region and, therefore, as is the case with carbonyl reductase [32], does not appear to contain prosthetic groups with absorption in this spectral region.
Using atomic-absorption spectroscopy, we found that purified PG-9-KR contains 1.9 mol Zn2+/mol enzyme, calculated on the basis of a molecular mass of 30 kDa. Whether the bound Zn2+ has a structural and/or catalytic function has not been investigated. Of interest is the observation that the bound Zn2+ must be tightly bound to the enzyme since it cannot be released on dialysis against EDTA-containing buffer. This also suggests the Zn2+ found is unlikely to be adventitiously bound to the protein.
Immunological relationship between PG-9-KR and carbonyl reductase
The immunological cross-reactivity of polyclonal antibodies raised against pig kidney PG-9-KR with human kidney PG-9-KR and with human brain carbonyl reductase was investigated by Western blot analysis as shown in Fig. 5 . The yielded rabbit-anti-(pig kidney PG-9-KR) polyclonal antibodies are highly specific for PC-9-KR (pig kidney), since only a single band is immunologically stained (Fig. S B, lane  1) upon blotting of an impure PG-9-KR fraction (Fig. 5 A,  lane 1) . These specific antibodies also recognize human kidney PG-9-KR (Fig. SB, lane 4) and human brain carbonyl reductase ( Fig. 5 B, lane 3) . We therefore conclude that PG-9-KR and carbonyl reductase are immunologically similar enzymes. The observed different molecular masses of pig kidney PG-9-KR and human kidney PG-9-KR (Fig. 5, lanes 2  and 4) , are most likely due to the different enzyme sources, since Fig. S also shows that the two human enzymes (lanes 3 and 4) have approximately the same molecular mass.
Amino acid composition
The amino acid composition for pig kidney PG-9-KR is shown in Table 7 and compared with those of PG-9-KR (form 1) from pig kidney [19], carbonyl reductase from human brain [32] , carbonyl reductase from human placenta [54] and ketone reductase from chicken kidney [47] . From these data, it is clear Table 7 . Comparison of the amino acid compositions of PG-9-KR with carbonyl reductase and ketone reductase. The valiies in column (a) are for the enzyme from pig kidney (this work). The number of residues were estimated on the basis of a molecular mass of 30 kDa. Column (b), PG-9-KR from pig kidney [19] . Column (c), carbonyl reductase from human brain [32] . Column (d), amino acid sequence deduced from the sequence of carhonyl reductase, c-DNA originally isolated from human placenta [54] . Column (e), ketone reductase from chicken kidney [47] . n.d., not determined.
Amino acid
Residues/mol enzyme that the amino acid compositions are similar and that any variations are in the order expected for enzymes isolated from different sources. In any case, the minimal interpretation that the above enzymes belong to the same family appears appropriate.
Comparison of PG-9-KR and carbonyl reductase on the basis of their amino acid sequences
Edman degradation of both pig kidney and human kidney PG-9-KR failed, strongly suggesting that the N-terminus of the enzyme is blocked, as has been reported for carbonyl reductase [54] . Comparison of the sequences of five tryptic peptides obtained from pig kidney PG-9-KR with the known amino acid sequence [54] , deduced from the nucleotide sequence of carbonyl reductase from human placenta, is shown in Fig. 6 . The identity between the sequences is > go%, which is unexpected in view of the different origin of the two proteins (pig kidney or human placenta). Since these five peptides constitute approximately 25% of the PG-9-KR sequence, it seems appropriate to conclude that PG-9-KR and carbonyl reductase exhibit highly conserved sequences and are, in fact, identical enzymes.
CONCLUSIONS
The data presented in this work provide evidence for the identity of PG-9-KR and carbonyl reductase. This conclusion is based on comparing several properties of PG-9-KR and carbonyl reductase, such as catalytic properties, stereospecificity of hydrogen transfer from NADPH, immunological similarity, amino acid composition and amino acid sequence data. Furthermore, the catalytic data on prostaglandins cast doubt on a role of PG-9-KK in prostaglandin metabolism. Since the role of carbonyl reductase is presently unknown, the physiological function of this ubiquitous enzyme remains an important question for further studies. The sequenced peptides from pig kidney PG-9-KR (underlined) are aligned with the sequence of human placenta carbonyl reductase from [54] . Matching amino acids are denoted by vertical lines. Amino acid X could not be identified. The sequence identity is > 90%. 
